Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Dickstein

Showing results (161-170 of 372) with videos related to

Pageof 38
Sort By:
International Journal of Cardiology|October 11, 2012
Intravenous immunoglobulin does not reduce left ventricular remodeling in patients with myocardial dysfunction during hospitalization after acute myocardial infarctionLars Gullestad, Stein Orn, Kenneth Dickstein, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 4, 2019
Cardiac resynchronization therapy pacemaker or cardiac resynchronization therapy defibrillator: what determines the choice?-findings from the ESC CRT Survey IICamilla Normand, Cecilia Linde, Nigussie Bogale, et al.
Lancet (London, England)|November 20, 2009
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trialMarvin A Konstam, James D Neaton, Kenneth Dickstein, et al.
European Journal of Heart Failure|July 16, 2020
Implications of serial measurements of natriuretic peptides in heart failure: insights from BIOSTAT-CHFMuhammad Zubair Israr, Andrea Salzano, Yoshiyuki Yazaki, et al.
Journal of the American College of Cardiology|February 16, 2018
Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial FibrillationJoão Pedro Ferreira, Nicolas Girerd, John Gregson, et al.
The New England Journal of Medicine|September 4, 2013
Cardiac-resynchronization therapy in heart failure with a narrow QRS complexFrank Ruschitzka, William T Abraham, Jagmeet P Singh, et al.
Diabetes Care|July 11, 2022
Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker StudyHertzel C Gerstein, Sibylle Hess, Brian Claggett, et al.
European Journal of Heart Failure|March 20, 2021
Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin-angiotensin-aldosterone system in patients with heart failureEva M Boorsma, Jozine M Ter Maaten, Kevin Damman, et al.
European Journal of Heart Failure|October 31, 2009
Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemiaStefan D Anker, Josep Comin Colet, Gerasimos Filippatos, et al.
Kardiologia Polska|November 9, 2018
Do we differ in terms of indications and demographics in cardiac resynchronisation recipients in Poland? Insights from the European CRT Survey II RegistryDamian Łasocha, Maciej Sterliński, Mateusz Tajstra, et al.
Pageof 38

Showing results (161-170 of 372) with videos related to

Sort By:
Pageof 38
International Journal of Cardiology|October 11, 2012
Intravenous immunoglobulin does not reduce left ventricular remodeling in patients with myocardial dysfunction during hospitalization after acute myocardial infarctionLars Gullestad, Stein Orn, Kenneth Dickstein, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 4, 2019
Cardiac resynchronization therapy pacemaker or cardiac resynchronization therapy defibrillator: what determines the choice?-findings from the ESC CRT Survey IICamilla Normand, Cecilia Linde, Nigussie Bogale, et al.
Lancet (London, England)|November 20, 2009
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trialMarvin A Konstam, James D Neaton, Kenneth Dickstein, et al.
European Journal of Heart Failure|July 16, 2020
Implications of serial measurements of natriuretic peptides in heart failure: insights from BIOSTAT-CHFMuhammad Zubair Israr, Andrea Salzano, Yoshiyuki Yazaki, et al.
Journal of the American College of Cardiology|February 16, 2018
Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial FibrillationJoão Pedro Ferreira, Nicolas Girerd, John Gregson, et al.
The New England Journal of Medicine|September 4, 2013
Cardiac-resynchronization therapy in heart failure with a narrow QRS complexFrank Ruschitzka, William T Abraham, Jagmeet P Singh, et al.
Diabetes Care|July 11, 2022
Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker StudyHertzel C Gerstein, Sibylle Hess, Brian Claggett, et al.
European Journal of Heart Failure|March 20, 2021
Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin-angiotensin-aldosterone system in patients with heart failureEva M Boorsma, Jozine M Ter Maaten, Kevin Damman, et al.
European Journal of Heart Failure|October 31, 2009
Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemiaStefan D Anker, Josep Comin Colet, Gerasimos Filippatos, et al.
Kardiologia Polska|November 9, 2018
Do we differ in terms of indications and demographics in cardiac resynchronisation recipients in Poland? Insights from the European CRT Survey II RegistryDamian Łasocha, Maciej Sterliński, Mateusz Tajstra, et al.
Pageof 38